Aktis Oncology achieves first milestone payment in 2024? | Binary | | | 7 months ago | |
Development delay announced by Aktis Oncology or Eli Lilly in 2024? | Binary | | | 7 months ago | |
Eli Lilly acquires additional stake in Aktis Oncology in 2024? | Binary | | | 7 months ago | |
Clinical trial stage for Aktis Oncology’s anticancer drugs by end of 2024 | Categorical | | | 7 months ago | |
Total milestone payments to Aktis Oncology in 2024 | Categorical | | | 7 months ago | |
How many new anticancer radiopharmaceuticals will enter clinical trials by the end of 2025? | Categorical | | | 7 months ago | |
Will the collaboration successfully complete a phase 1 clinical trial of a new anticancer radiopharmaceutical by the end of 2025? | Binary | | | 7 months ago | |
Will Aktis Oncology and Eli Lilly terminate their collaboration by the end of 2025? | Binary | | | 7 months ago | |
Royalty rates for Aktis Oncology’s anticancer drug sales by end of 2024 | Categorical | | | 7 months ago | |
Will Aktis Oncology receive the next milestone payment from Eli Lilly by the end of 2025? | Binary | | | 7 months ago | |
What will be the revenue from sales of anticancer radiopharmaceuticals developed by Aktis Oncology and Eli Lilly by the end of 2025? | Categorical | | | 7 months ago | |
How many additional investments in radiopharmaceuticals will Eli Lilly make by the end of 2025? | Categorical | | | 7 months ago | |